As of 2025-09-16, the Relative Valuation of Foghorn Therapeutics Inc. (FHTX) is (11.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.99 USD, the upside of Foghorn Therapeutics Inc. based on Relative Valuation is -329.2%.
The range of the Relative Valuation is (9.04) - (15.07) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 11.3x | 7.8x |
| Forward P/E multiples | 6.8x - 11.8x | 9.3x |
| Fair Price | (9.04) - (15.07) | (11.44) |
| Upside | -281.2% - -402.0% | -329.2% |
| Date | P/E |
| 2025-09-15 | -3.74 |
| 2025-09-12 | -3.89 |
| 2025-09-11 | -3.96 |
| 2025-09-10 | -3.86 |
| 2025-09-09 | -4.07 |
| 2025-09-08 | -4.31 |
| 2025-09-05 | -4.33 |
| 2025-09-04 | -4.04 |
| 2025-09-03 | -3.95 |
| 2025-09-02 | -3.96 |
| 2025-08-29 | -3.79 |
| 2025-08-28 | -3.76 |
| 2025-08-27 | -4.06 |
| 2025-08-26 | -4.15 |
| 2025-08-25 | -3.94 |
| 2025-08-22 | -4.17 |
| 2025-08-21 | -3.78 |
| 2025-08-20 | -3.94 |
| 2025-08-19 | -3.62 |
| 2025-08-18 | -3.82 |
| 2025-08-15 | -3.73 |
| 2025-08-14 | -3.86 |
| 2025-08-13 | -3.88 |
| 2025-08-12 | -3.65 |
| 2025-08-11 | -3.53 |
| 2025-08-08 | -3.43 |
| 2025-08-07 | -3.73 |
| 2025-08-06 | -3.67 |
| 2025-08-05 | -3.75 |
| 2025-08-04 | -3.85 |
| 2025-08-01 | -3.74 |
| 2025-07-31 | -3.94 |
| 2025-07-30 | -4.09 |
| 2025-07-29 | -4.43 |
| 2025-07-28 | -4.87 |
| 2025-07-25 | -4.64 |
| 2025-07-24 | -4.64 |
| 2025-07-23 | -4.85 |
| 2025-07-22 | -4.75 |
| 2025-07-21 | -4.57 |
| 2025-07-18 | -4.60 |
| 2025-07-17 | -4.57 |
| 2025-07-16 | -4.41 |
| 2025-07-15 | -4.35 |
| 2025-07-14 | -4.41 |
| 2025-07-11 | -4.05 |
| 2025-07-10 | -4.05 |
| 2025-07-09 | -4.13 |
| 2025-07-08 | -3.67 |
| 2025-07-07 | -3.58 |